Enhanced urinary CXCL10 levels: a key urinary marker for rejection in kidney graft recipients
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12506-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 04.08.2026. Verfasst von Sahar Janfeshan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Chemokine CXCL10, Kidney Transplantation, Graft Rejection. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. roozbehj@hotmail.com.
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Janfeshan, S., Yaghobi, R., Afshari, A., & Roozbeh, J. (2026). Enhanced urinary CXCL10 levels: a key urinary marker for rejection in kidney graft recipients. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12506-2
Vancouver
Janfeshan S, Yaghobi R, Afshari A, Roozbeh J. Enhanced urinary CXCL10 levels: a key urinary marker for rejection in kidney graft recipients. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12506-2
BibTeX
@article{Janfeshan2026,
author = {Janfeshan, Sahar and Yaghobi, Ramin and Afshari, Afsoon and Roozbeh, Jamshid},
title = {Enhanced urinary CXCL10 levels: a key urinary marker for rejection in kidney graft recipients},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12506-2}
}
EUVIMED